Eledon Pharmaceuticals, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Eledon Pharmaceuticals, Inc. (ELDN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $1.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-03-31 was $1.00K, a 98.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-12-31 was -$4.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-09-30 was -$3.00K, a 130.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-06-30 was $11.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $54.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$55.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-03 | -$3.00K derived: sum of 2 quarters · filed 2017-05-03 | -$6.00K derived: sum of 3 quarters · filed 2017-05-03 | $5.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$7.00K derived: sum of 2 quarters · filed 2017-03-03 | $4.00K derived: sum of 3 quarters · filed 2017-03-03 | $54.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | -$3.00K 10-Q · filed 2016-11-03 | $8.00K derived: sum of 2 quarters · filed 2016-11-03 | $58.00K 10-Q · filed 2016-11-03 | -$5.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | $11.00K 10-Q · filed 2016-08-04 | $61.00K 10-Q · filed 2016-08-04 | -$2.00K derived: sum of 3 quarters · filed 2017-05-03 | $8.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | $50.00K 10-Q · filed 2017-05-03 | -$13.00K derived: sum of 2 quarters · filed 2017-05-03 | -$3.00K derived: sum of 3 quarters · filed 2017-05-03 | -$5.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$53.00K derived: sum of 2 quarters · filed 2017-03-03 | -$55.00K derived: sum of 3 quarters · filed 2017-03-03 | -$55.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $10.00K 10-Q · filed 2016-11-03 | $8.00K derived: sum of 2 quarters · filed 2016-11-03 | $8.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | -$2.00K 10-Q · filed 2016-08-04 | -$2.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |